Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – A retrospective multicenter study conducted in France concludes that combination chemotherapy with gemcitabine and oxaliplatin is effective in patients with advanced hepatocellular carcinoma…
NEW YORK (Reuters Health) – Compared to open radical prostatectomy in patients with recurrent prostate cancer after failed primary therapy, robotic-assisted laparoscopic prostatectomy “is an attractive alternative”, and…
NEW YORK (Reuters Health) – Whole-body (WB) scans using either magnetic resonance imaging (MRI) or positron-emission tomography (PET) with CT, both have high sensitivity and specificity in detecting…
NEW YORK (Reuters Health) – The theoretical advantage of a retrograde rather than antegrade approach to nerve sparing during robot-assisted radical prostatectomy (RARP) has been confirmed in a…
NEW YORK (Reuters Health) – After platinum failure in patients with advanced non-small-cell lung cancer, adding aflibercept to standard second-line docetaxel treatment does not improve overall survival (OS),…
NEW YORK (Reuters Health) – Using a hybrid of single-photon emission computed tomography (SPECT) and computed tomography (CT) to look for positive lymph nodes in melanoma patients helps…
NEW YORK (Reuters Health) – In the first-line treatment of advanced colorectal cancer, the combination of cediranib and chemotherapy is comparable to bevacizumab plus chemotherapy in terms of…
NEW YORK (Reuters Health) – Chemotherapy-induced delayed nausea remains a significant problem, despite the availability of second-generation antiemetics, researchers say. In a study they conducted, over half of…
NEW YORK (Reuters Health) – In advanced ovarian cancer, extensive lymph node dissection in a second-look operation does not improve survival, Italian researchers say. Their randomized trial addressed…
NEW YORK (Reuters Health) – Patients with esophageal cancer appear to have equally good survival after minimally invasive esophagectomy (MIE) or traditional open surgery, according to a new…
